| Literature DB >> 28219662 |
Nadine Ruecker1, Robert Jansen2, Carolina Trujillo1, Susan Puckett1, Pradeepa Jayachandran1, Gerardo G Piroli3, Norma Frizzell3, Henrik Molina4, Kyu Y Rhee2, Sabine Ehrt5.
Abstract
Enzymes of central carbon metabolism are essential mediators of Mycobacterium tuberculosis (Mtb) physiology and pathogenicity, but are often perceived to lack sufficient species selectivity to be pursued as potential drug targets. Fumarase (Fum) is an enzyme of the canonical tricarboxylic acid cycle and is dispensable in many organisms. Transposon mutagenesis studies in Mtb, however, indicate that Fum is required for optimal growth. Here, we report the generation and characterization of a genetically engineered Mtb strain in which Fum expression is conditionally regulated. This revealed that Fum deficiency is bactericidal in vitro and during both the acute and chronic phases of mouse infection. This essentiality is linked to marked accumulations of fumarate resulting in protein and metabolite succination, a covalent modification of cysteine thiol residues. These results identify Mtb Fum as a potentially species-specific drug target whose inactivation may kill Mtb through a covalently irreversible form of metabolic toxicity.Entities:
Keywords: central carbon metabolism; drug target; fumarase; succination; tuberculosis
Mesh:
Substances:
Year: 2017 PMID: 28219662 PMCID: PMC5357164 DOI: 10.1016/j.chembiol.2017.01.005
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116